About the journal

Cobiss

Srpski arhiv za celokupno lekarstvo 2018 Volume 146, Issue 9-10, Pages: 524-529
https://doi.org/10.2298/SARH170707177B
Full text ( 1120 KB)
Cited by


Immunohistochemical evaluation of insulin-like growth factor receptor 1 in breast cancer

Batinić-Škipina Danijela (University Hospital Foča, Foča, Republic of Srpska, Bosnia and Herzegovina)
Marić Radmil (University Hospital Foča, Foča, Republic of Srpska, Bosnia and Herzegovina)
Tadić-Latinović Ljiljana (University Clinical Centre of the Republic of Srpska, Banjaluka, Bosnia and Herzegovina)
Erić Dražan (University Hospital Foča, Foča, Republic of Srpska, Bosnia and Herzegovina)
Lalović Nenad (University Hospital Foča, Foča, Republic of Srpska, Bosnia and Herzegovina)

Introduction/Objective. Activation of insulin-like growth factor receptor (IGF-1R) results in cell transition from growth phase to synthesis phase of cell cycle. Breast cancer is categorized into prognostic and therapeutic subtypes based upon hormone receptor, estrogen receptor (ER), and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER-2) expression. The objective of this study was to examine the expression of IGF-1R in а specific subtype invasive breast cancer and its correlation with basic histopathological and immunohistochemical prognostic parameters. Methods. Formalin-fixed paraffin-embedded tumor samples were obtained from 129 female patients with invasive breast cancer (I–III disease stage) with the follow-up ranging 36–108 months (average 48 months). For immunohistochemical staining, we used monoclonal antibodies for ER, PR, IGF-1R, and polyclonal antibody for HER-2. Results. IGF-1R inversely correlated with tumor stage (p = 0.017), tumor grade (p = 0.001), HER-2 (p = 0.003), whereas significant positive correlation was found with multifocality/multicentricity of breast cancer (p = 0.036), ER (p = 0.001) and PR (p = 0.0001) expression. Cox-regression analysis for relapse-free survival (RFS) showed that disease stage (p = 0.039) and HER-2 (p = 0.033) were independent prognostic factors. IGF-1R did not predict clinical outcome in patients with breast cancer (p = 0.488, Kaplan–Meier test for RFS). Conclusion. Patients with low stage and grade hormone-dependent breast cancer had a significantly higher IGF-1R expression than patients with triple negative or HER-2 overexpressed cancer. The present findings also highlight that IGF-1R expression in multicentric/multifocal breast cancer supports the key roles in tumor initiation.

Keywords: insulin-like growth factor 1 receptor (IGF-1R), hormone-dependent breast cancer, HER-2